Today' anchor Al Roker was first diagnosed after bloodwork at a routine checkup showed elevated prostate specific antigen ...

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...

A sustained reduction in deaths from prostate cancer was observed with prostate-specific antigen (PSA) testing in long-term ...

Opposition parties at Queen’s Park are renewing calls for the government to cover a simple blood test that helps detect ...

Prostate cancer is the most common form of cancer in the UK, according to Prostate Cancer UK. Cancer Research UK says ...

The favorable effects observed in the study "consolidate the finding that metformin not only improves anthropometric outcomes ...

Adding the drug enzalutamide to standard hormone therapy reduced the risk of premature death by more than 40% in patients ...

Grape seed extract—a dietary supplement made from the seeds of wine grapes—has been investigated to see if it can help reduce ...

A new phase 3 trial reveals that combining enzalutamide and leuprolide significantly improves overall survival for men with ...

The baffling question: why does prostate cancer relapse quickly in some patients while stabilising in others? Recent ...

A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer ...

BERLIN — For men with high-risk biochemically recurrent prostate cancer, adding enzalutamide (Xtandi) to standard androgen ...